Latest NUVL Analyst Ratings & Recommendations
Recent analyst recommendations with rating changes and price target updates (last 90 days)
| Date | Analyst | Firm | Action | Rating | Price Target |
|---|---|---|---|---|---|
| Swayampakula Ramakanth | HC Wainwright | Maintains | Hold | $124.00 | |
| Jeffrey Walch | Bernstein | Downgrades | Hold | $172.00 → $124.00 -48.00 (-27.9%) | |
| Charles Zhu | LifeSci Capital | Downgrades | Hold | $124.00 | |
| Laura Prendergast | Stifel Nicolaus | Downgrades | Hold | $135.00 → $124.00 -11.00 (-8.2%) | |
| Google Biotechnology | TipRanks - Google | Reiterates | Hold | $90.00 → $134.00 +44.00 (48.9%) | |
| PerPlexity Biotechnology | TipRanks - PerPlexity | Reiterates | Hold | $99.00 → $85.00 -14.00 (-14.1%) | |
| Anthropic Biotechnology | TipRanks - Anthropic | Downgrades | Buy | $93.00 → $139.00 +46.00 (49.5%) | |
| xAi Biotechnology | TipRanks - xAI | Reiterates | Hold | $93.00 → $133.00 +40.00 (43.0%) | |
| Laura Prendergast | Stifel Nicolaus | Upgrades | Hold | $135.00 → $124.00 -11.00 (-8.2%) | |
| John Newman | Canaccord Genuity | Upgrades | Hold | $126.00 | |
| OpenAI Biotechnology | TipRanks - OpenAI | Reiterates | Hold | $94.00 → $129.00 +35.00 (37.2%) | |
| David Nierengarten | Wedbush | Upgrades | Hold | $125.00 → $124.00 -1.00 (-0.8%) | |
| Bradley Canino | Guggenheim | Downgrades | Hold | $151.00 → $124.00 -27.00 (-17.9%) | |
| Gregory Renza | Truist | Upgrades | Hold | $140.00 → $124.00 -16.00 (-11.4%) | |
| David Dai | UBS | Downgrades | Hold | $138.00 → $124.00 -14.00 (-10.1%) | |
| Eva Fortea Verdejo | Wells Fargo | Upgrades | Hold | $116.00 → $124.00 +8.00 (6.9%) | |
| John Newman | Canaccord Genuity | Downgrades | Hold | $126.00 | |
| Bradley Canino | Guggenheim | Upgrades | Hold | $151.00 → $124.00 -27.00 (-17.9%) | |
| Joshua Schimmer | Cantor Fitzgerald | Upgrades | Hold | - | |
| Kelsey Goodwin | Piper Sandler | Upgrades | Hold | $124.00 | |
| Marc Frahm | TD Cowen | Downgrades | Hold | $124.00 | |
| Etzer Darout | Barclays | Downgrades | Hold | $152.00 → $124.00 -28.00 (-18.4%) | |
| Anupam Rama | JP Morgan | Downgrades | Hold | $147.00 → $124.00 -23.00 (-15.7%) | |
| Colleen M. Kusy | Baird | Downgrades | Hold | $158.00 → $122.85 -35.15 (-22.3%) | |
| Christopher Raymond | Raymond James | Upgrades | Hold | - |
